Mike Doustdar Talks Strong Demand for Weight Loss Pills
Bloomberg Talks · Bloomberg
January 13, 202611m 22s
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.
See omnystudio.com/listener for privacy information.